Spirit Airlines raises going-concern doubts, months after exiting bankruptcy
The company expects these pressures to persist through the rest of the year, adding to operational uncertainty. Last month, Spirit said it would furlough about 270 pilots, while demoting another 140, to conserve cash.
The Florida-based airline, known for its bright yellow livery, had filed for bankruptcy protection last November, after years of losses, failed merger attempts and heavy debt.
It was the first major U.S. carrier to file for Chapter 11 since 2011. It emerged from bankruptcy in March after a court approved restructuring backed by its creditors.
Uncertainty stemming from President Donald Trump's sweeping tariffs and budget cuts have prompted travelers to curb spending and reassess plans.
The airline said on Monday that its credit-card processor has asked it to set aside more funds as collateral or risk losing its contract, which is set to expire on Dec. 31.
To address the concerns, Spirit said it plans to bolster liquidity by selling or monetizing aircraft and real estate and shedding excess airport gate capacity.
Uncertainty over meeting minimum liquidity covenants and the outcome of talks with stakeholders have raised substantial doubt about the company's ability to continue as a going concern over the next 12 months, it said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
16 minutes ago
- Time of India
Trump says no imminent plans to penalise China for buying Russian oil
US President Donald Trump said on Friday he did not immediately need to consider retaliatory tariffs on countries such as China for buying Russian oil but might have to "in two or three weeks." Trump has threatened sanctions on Moscow and secondary sanctions on countries that buy its oil if no moves are made to end the war in Ukraine. China and India are the top two buyers of Russian oil. The president last week imposed an additional 25 per cent tariff on Indian goods, citing its continued imports of Russian oil. However, Trump has not taken similar action against China. He was asked by Fox News' Sean Hannity if he was now considering such action against Beijing after he and Russian President Vladimir Putin failed to produce an agreement to resolve or pause Moscow's war in Ukraine. "Well, because of what happened today, I think I don't have to think about that," Trump said after his summit with Putin in Alaska. "Now, I may have to think about it in two weeks or three weeks or something, but we don't have to think about that right now. I think, you know, the meeting went very well." Chinese President Xi Jinping's slowing economy will suffer if Trump follows through on a promise to ramp up Russia-related sanctions and tariffs. Xi and Trump are working on a trade deal that could lower tensions - and import taxes - between the world's two biggest economies. But China could be the biggest remaining target, outside of Russia, if Trump ramps up punitive measures.
Hans India
16 minutes ago
- Hans India
US-India Trade Talks Face Setback As American Delegation Postpones New Delhi Visit
The upcoming round of negotiations for the India-US bilateral trade agreement faces an uncertain timeline as the American delegation is expected to postpone its planned visit to New Delhi scheduled for later this month. According to an unnamed official speaking to PTI, the sixth round of discussions, originally set for August 25-29, will likely be rescheduled due to mounting trade tensions between the two nations. This development occurs against the backdrop of deteriorating trade relations, with Washington implementing punitive tariff measures on Indian exports. Since August 7, the United States has maintained a 25 percent duty on Indian goods, and an additional 25 percent penalty is scheduled to take effect from August 27. This second tariff serves as punishment for India's continued purchases of crude oil and military equipment from Russia, despite ongoing international sanctions. The combined impact of these tariffs will result in a substantial 50 percent duty on Indian exports entering the American market, creating significant challenges for Indian exporters and potentially disrupting established trade patterns. The timing of these measures coincides with America's sustained pressure on New Delhi to liberalize access to politically sensitive sectors, particularly agriculture and dairy markets. India has maintained a firm stance against such demands, categorically refusing to make concessions that could jeopardize the economic well-being of small-scale farmers and cattle rearers. The Indian government views these sectors as crucial for rural livelihoods and food security, making them non-negotiable areas in trade discussions. Despite the current diplomatic friction and trade disputes, commercial relationships between the two countries continue to demonstrate resilience and growth. Official commerce ministry statistics reveal that India's exports to the United States experienced robust growth of 21.64 percent, reaching USD 33.53 billion during the April-July 2025 period. Simultaneously, imports from America increased by 12.33 percent to USD 17.41 billion during the same timeframe. The United States has emerged as India's most significant trading partner during this period, with total bilateral trade volume reaching USD 12.56 billion. This figure underscores the substantial economic interdependence between the two nations, despite ongoing political and policy disagreements. Both governments have previously committed to completing the initial phase of the bilateral trade agreement by fall 2025, with ambitious long-term objectives of expanding bilateral trade from the current USD 191 billion to USD 500 billion by 2030. These targets reflect the enormous potential for economic cooperation between the world's largest democracy and its most powerful economy. Following President Donald Trump's announcement of additional tariffs on Indian exports, Prime Minister Narendra Modi used his Independence Day address to advocate for increased domestic production and consumption of Indian-made products. The Prime Minister emphasized his government's unwavering commitment to protecting the interests of India's agricultural community. Modi declared his resolute opposition to any policies that could harm Indian farmers, fishermen, and cattle rearers, stating that his administration would serve as a protective barrier against detrimental foreign trade demands. He reinforced India's position of refusing to compromise on policies affecting these vulnerable economic sectors. Recent diplomatic developments may influence the trajectory of trade relations between the two countries. A significant meeting between President Trump and Russian President Vladimir Putin took place in Alaska over the weekend, raising speculation about potential improvements in Washington-Moscow relations that could indirectly benefit India. During discussions about the Ukraine conflict, Trump adopted a more measured approach toward sanctions, suggesting he might reconsider additional punitive measures in the coming weeks. His statement that immediate secondary sanctions were unnecessary and could be "devastating" for the targeted countries has generated hope that the additional 25 percent tariff on Indian goods might be reconsidered. The postponement of trade negotiations reflects the complex interplay of geopolitical considerations, domestic political pressures, and economic interests that characterize modern international trade relationships. Both nations must navigate these challenges while maintaining their strategic partnership and shared democratic values. The delay also highlights the difficulties inherent in negotiating comprehensive trade agreements between major economies with different development priorities and political constraints. As India continues to protect its agricultural sector and rural communities, and the United States pursues its own trade and foreign policy objectives, finding mutually acceptable solutions becomes increasingly challenging. The rescheduling of the American delegation's visit represents a temporary setback rather than a permanent breakdown in negotiations, with both countries likely to resume discussions once immediate tensions subside and diplomatic conditions become more favorable for productive dialogue.
Mint
an hour ago
- Mint
Aurobindo Pharma expects China plant to break even at EBITDA level this year
New Delhi, Aurobindo Pharma expects its China facility to break even in the third quarter of the current financial year, according to its CFO Santhanam Subramanian. The Hyderabad-based drug maker commenced operations at the facility in the last week of November 2024 and is now ramping up production. "This facility with an initial capacity of 2 billion units plus is ramping up as expected and will begin contributing to revenue in the coming quarters and is expected to break even at the EBITDA level by Q3 FY26," Subramanian said in an analyst call. He noted that around USD 145 million has been invested in the facility, which commenced production and invoicing in Q4 FY25 and Q1 FY26, respectively. Elaborating on other investments, Subramanian said the company has invested about USD 70 million in two US facilities, with production expected to start in the current fiscal year. Elaborating further, he noted that the company plans to file for more than 20 products in the US and Europe from its Eugia-V plant in Visakhapatnam. He noted that the company has invested around USD 30 million in the Biologics CMO business so far, and the balance of USD 100 million plus capital is expected to be invested by March 2027. On business outlook, Subramanian stated: "Looking ahead, we remain optimistic about sustaining our growth momentum. Our confidence is supported by expected volume expansion, continued product launches and a stable pricing environment, especially in the US and Europe". Commercial operations ramping up at new manufacturing sites would further support the topline growth and margin improvement in the upcoming quarters, he added. "We are confident of achieving our internal target margin of 20-21 per cent in FY26," Subramanian stated. Aurobindo Pharma reported a 10 per cent year-on-year dip in its consolidated net profit to ₹ 824 crore for the June quarter, due to a fall in sales in the US and I business vertical. Its revenue from operations increased to ₹ 7,868 crore for the June quarter against ₹ 7,567 crore in the year-ago period. This article was generated from an automated news agency feed without modifications to text.
